Renovia Study Results Published in Neurology and Urodynamics Show Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence
Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards
Boston, MA – March 28, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced that it has received a nomination for MedTech Company...
Renovia Names Jim O’Connor as General Counsel & Senior Vice President, Strategic Development
Boston, MA – March 14, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Jim O’Connor has been promoted to General Counsel...
Renovia Appoints John A. Fallon, M.D. to its Board of Directors
Boston, MA – January 9, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced John A. Fallon, M.D. has joined its Board of...
Renovia Launches “REDUCE” – a Multi-Center Randomized Controlled Trial to Study Next-Generation leva® Pelvic Digital Therapeutic System for Urinary Incontinence
Six-Center Study Will Compare Renovia’s Pelvic Digital Therapeutic System to Standard of Care Pelvic Floor Muscle Exercises in Home-based Treatment of Stress-dominant Urinary Incontinence Boston, MA – November 12, 2018 – Renovia Inc. (“Renovia”), a company dedicated...
Renovia Appoints Tara Butler, M.D. to its Board of Directors
Boston, MA – October 31, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Tara Butler, M.D. has joined its Board of Directors....
Renovia Appoints Dan Levangie to its Board of Directors
Boston, MA – Sept 12, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Dan Levangie has joined its Board of Directors. "Dan...
Renovia Supports ACOG and WPSI Recommendations Related to Screening for Urinary Incontinence
Renovia is Developing a Product Pipeline to Better Diagnose and Treat Women Affected by Pelvic Floor Disorders, including Urinary Incontinence Boston, MA – August 28, 2018 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital...
Renovia Completes $42.3 Million Series B Financing
Financing Will Accelerate Clinical Research, Development and New Digital Therapeutic Device Launches Targeted at Pelvic Floor Disorders Boston, MA – August 21, 2018 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital...
Renovia Announces the Appointment of Jim O’Connor as General Counsel
Boston, MA- February 25th, 2018- Renovia, a company dedicated to discovering and delivering innovative medical solutions and technology combined with digital health to help individuals suffering from pelvic floor disorders, announced the appointment of Jim O’Connor as...
Renovia Announces the Appointment of Two Clinical Leaders in Women’s Healthcare
Boston, MA – December 13th, 2017 Renovia, a company dedicated to discovering and delivering innovative medical solutions and technology combined with digital health to help individuals suffering from pelvic floor disorders, announced the appointment of Samantha...